SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-24-002071
Filing Date
2024-04-03
Accepted
2024-04-03 08:08:38
Documents
1
Group Members
ALTAMONT PHARMACEUTICAL HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM SC 13G altamont_sc13ga1.htm SC 13G/A 43844
  Complete submission text file 0001683168-24-002071.txt   45611
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91201 | Film No.: 24816906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128
Business Address 3031 TISCH WAY SUITE 505 SAN JOSE CA 95128 (408) 479-7842
Altamont Pharmaceutical Holdings, LLC (Filed by) CIK: 0001745878 (see all company filings)

IRS No.: 812760468 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A